N/A
Manufactured by Amici Pharmaceuticals, LLC.
1,861 FDA adverse event reports analyzed
Last updated: 2026-04-15
CEFPODOXIME PROXETIL is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Amici Pharmaceuticals, LLC.. The most commonly reported adverse reactions for CEFPODOXIME PROXETIL include DIARRHOEA, PYREXIA, PNEUMONIA, DYSPNOEA, COUGH. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CEFPODOXIME PROXETIL.
Out of 915 classified reports for CEFPODOXIME PROXETIL:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 1,861 FDA FAERS reports that mention CEFPODOXIME PROXETIL. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DIARRHOEA, PYREXIA, PNEUMONIA, DYSPNOEA, COUGH, FATIGUE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Amici Pharmaceuticals, LLC. in connection with CEFPODOXIME PROXETIL. Always verify the specific product and NDC with your pharmacist.